trending Market Intelligence /marketintelligence/en/news-insights/trending/ctAcUOJEMIDn0NjC3oKDHg2 content esgSubNav
In This List

Assembly Biosciences appoints director

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Assembly Biosciences appoints director

Assembly Biosciences Inc. increased the size of its board to eight members with the appointment of Sue Mahony as a director.

Mahony is president of Lilly Oncology, a senior vice president at Eli Lilly and Co. and a member of the company's executive committee.